openPR Logo
Press release

Animal Model Market | Genoway SA, Eurofins Scientific SE, Crown Bioscience, Inc., Envigo CRS SA, and Transposagen Biopharmaceuticals, Inc

02-22-2019 11:53 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fact.MR

/ PR Agency: Fact.MR
Animal Model

Animal Model

Key Findings

Developing Regions to Overpower Developed Ones With Regard to Demand

The Asian territory is on the verge of evolving as the next big destination for animal models. This growth can be attributed to various factors such as American and European pharmaceutical companies diversifying their research activities to curtail extra expenses and save costs. Although U.S and Europe have retained their legacy in the global market, their share has been witnessing a drastic downfall in the last few years due to APAC picking up the pace. Among all the Asian countries, China, India, Malaysia, and Singapore are anticipated to record robust demand, with China accounting for a major chunk of demand. While the popularity of inbred animals is picking up the steam, transgenic animals are also gathering significant momentum with rising preferences for super-immunodeficient and humanized animal models. Academic labs in China are poised to receive notable extent of governmental encouragement for medical research, standing out as one of the predominant factors pushing demand in the China animal model market.

Request Sample Report @ https://www.factmr.com/connectus/sample?flag=S&rep_id=1590 

Growing Need for Fulfilling Unmet Demand

The surging application of animal species to develop various novel therapy is foreseen to fortify growth of animal model market. Furthermore, escalating need for more novel drugs for catering the huge unmet demand is estimated to be a preeminent factor boosting demand. Multiplying prevalence of genetic disorders globally and evolving research field are poised to be the key growth determinants of the market. In addition, deployment of animal model for carrying out multiple studies of disease and human physiology is another chief factor bolstering growth of the market. However, facets such as high costs of the study and stringent regulatory framework is likely to restrict the market growth to a certain extent. In addition to that, rise pace of preclinical studies for therapeutic approvals and striking investments in R&D by key pharmaceutical companies are also some of the pivotal factors spurring market growth.

Market Definition

An animal on which certain pathological and biological experiments are carried out and tested, such animal is referred as an animal model. An animal model is used by virtue of its functional resemblance to the human body. In a bid to avoid any sort of discrepancy, various guidelines have been se, which have to be followed while taking an animal model for performing an experiment. Few of the major areas which animal models are widely employed include physiology, toxicology, biomedical research, neurological research, genetic research, cancer research, and xenotransplantation.

Browse Full Report @ https://www.factmr.com/report/1590/animal-model-market 

About the Report

Fact.MR offers a holistic and insightful industry overview of animal models. By making use of diligent methodologies and punctilious research, our experienced analysts deliver contemplated and definitive judgment on growth trajectory of the market. This helps the readers to get a holistic, unbiased, and precise visionary of the market.

The report offers a cutting-edge analysis of the animal model market, complemented by a pioneering forecast. Insights have been offered on the market size of animal model in terms of both value (US$ Mn) as well as volume (Thousand Units). Along with the market dynamics, several macroeconomic factors exerting profound influence on the animal model market have also been analyzed and included in the report. The industry dynamics primarily comprises of market growth drivers, market restraints, prevalent trends, and remunerative opportunities, which have been explained in detail for lucid understanding of the user.

This meticulous market study revolves around data procured from diverse sources and is further scrutinized with the help of various tools such as porter’s five forces analysis, value chain analysis, and market attractiveness analysis. These tools are specifically employed for attaining insights on potential of the market, which is further believed to grease the wheels for market players to turn profits by tapping into prime opportunities. All in all, the report serves as an exhaustive and all-inclusive repository of comprehensive analysis, profitable insights, and key aspects of animal model market.

Market prognosis of animal model market has been provided by discussing about pertinent segments such as species, application, end user, and region. Various types of species such as rats, mice, guinea pig, rabbits, monkeys, dogs, pigs, cats, and other species have been closely analyzed in this report. Application of animal model market across areas such as basic & applied research and drug discovery/development have also been closely studied and well- articulated in the report.

Moreover, end user segments such as academic & research institutions, pharmaceutical companies, biotechnology companies, contract research organizations (CROs), and other end users have also been scrutinized and highlighted in the report. This exhaustive research report tracks the animal model market across primary regional segments such as North America, Latin America, Europe, South Korea, APAC, and Middle East & Africa (MEA). Along with global, the report also sheds light on an exclusive coverage on the regional dynamics of the market.

Speak To Research Analyst for Detailed Insights @ https://www.factmr.com/connectus/sample?flag=AE&rep_id=1590 

Competitive Landscape

The report has featured major players operating in the market who are remarkably contributing to the overall market growth. The key players listed in the market include Genoway SA, Eurofins Scientific SE, Crown Bioscience, Inc., Envigo CRS SA, and Transposagen Biopharmaceuticals, Inc. These players are indulging in acquisitions, mergers, and takeovers to amplify their reach. These players are also resorting to brand new product fortification strategies for strengthening their foothold in the global market.

Besides the forenamed players, the report also features an exclusive outlook of other renowned companies operating in the animal model market.

Research Methodology

This research study on animal model market encompasses use of all-inclusive secondary sources, directories, and pertinent databases to identify and assemble information useful for animal model market. Primary sources comprise of industry personnel hailing from core industries, prominent suppliers, manufacturers, distributors, and others related to value chain of the industry. The overall market size has been estimated after a series of rigorous research and the market has been further split into several segments. The data points included in the report are subjected to another round of cross verification to avoid any sort of discrepancy.

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: www.factmr.com/

Read Industrial News : https://theswisstimes.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Animal Model Market | Genoway SA, Eurofins Scientific SE, Crown Bioscience, Inc., Envigo CRS SA, and Transposagen Biopharmaceuticals, Inc here

News-ID: 1609989 • Views:

More Releases from Fact.MR

Hemoglobinopathy Market Forecast Growing at 8.3% CAGR to Reach $1.7 Billion by 2034
04-24-2024 | Health & Medicine
Fact.MR
Hemoglobinopathy Market Forecast Growing at 8.3% CAGR to Reach $1.7 Billion by 2 …
In 2024, the global hemoglobinopathy market (ヘモグロビン症市場) is estimated to be worth US$788.1 million, with a projected compound annual growth rate (CAGR) of 8.3% through 2034. By 2034, the market size is expected to exceed US$1,745.7 million. The rise of genetic testing has led to a significant shift in the hemoglobinopathy market towards personalized medication. Companies are leveraging this trend to develop tailored treatment plans based on each patient's DNA
Sales Forecast of Elder Care Product Market to Reach US$ 56.7 Billion by 2034 with a 6.7% CAGR
04-24-2024 | Health & Medicine
Fact.MR
Sales Forecast of Elder Care Product Market to Reach US$ 56.7 Billion by 2034 wi …
The global elder care product market (高齢者介護製品市場) is anticipated to reach a value of US$ 29,600.2 million by 2024 and is expected to exceed US$ 56,719.4 million by 2034. Sales of these products are forecasted to grow at a CAGR of 6.7% through 2034, driven by the growing trend of aging-in-place. This trend is fueling innovations in technology integration, wearable health devices, and personalized safety solutions. Increasing awareness about elder
Veterinary Oncology Market Predicts 12% CAGR Through 2033 With a US$ 800 Million
04-24-2024 | Health & Medicine
Fact.MR
Veterinary Oncology Market Predicts 12% CAGR Through 2033 With a US$ 800 Million
In 2023, the veterinary oncology market (獣医腫瘍学市場) was valued at US$ 260 million, and it's anticipated to reach US$ 800 million by the end of 2033, with a projected compound annual growth rate (CAGR) of 12% from 2023 to 2033. Veterinary oncology focuses on caring for pets diagnosed with cancer, with the goal of enhancing their overall quality of life. Cancer is the leading cause of mortality among companion animals,
Sales of Luxury Eyewear are forecasted to reach US$ 56 billion by 2033
Sales of Luxury Eyewear are forecasted to reach US$ 56 billion by 2033
According to Fact.MR, a trusted provider of market research and competitive intelligence, the global Luxury Eyewear Market was valued at US$ 40 billion in 2023. Projections suggest that by the conclusion of 2033, this market is anticipated to escalate to US$ 56 billion. Forecasts indicate a steady Compound Annual Growth Rate (CAGR) of 3.4% in the global demand for luxury eyewear from 2023 to 2033. The surge in luxury eyewear sales

All 5 Releases


More Releases for Animal

Animal Model Market trends, Animal Model Market growth, Animal Model Market size …
Key Findings of Animal Model Market Developing Regions to Overpower Developed Ones With Regard to Demand The Asian territory is on the verge of evolving as the next big destination for animal models. This growth can be attributed to various factors such as American and European pharmaceutical companies diversifying their research activities to curtail extra expenses and save costs. Although U.S and Europe have retained their legacy in the global market, their
Animal Growth Promoter Market Outlook To 2023 – Bayer Animal Health, Biomin, B …
Nov 2018, New York USA (News)- Different categories of feed additives for farm animals are referred to as natural growth promoters (NGPs) or non-antibiotic growth promoters. They are commonly regarded as favorable alternatives to antibiotic growth promoters (AGPs) in livestock production. NGPs include predominantly organic acids, probiotics, prebiotics, synbiotics, phytogenics, tannins, feed enzymes and immune stimulants, an ongoing search for alternatives has created a large variety of NGPs for pigs,
Animal Antimicrobials and Antibiotics Market Key Players : Animal Health, Bayer …
The term antibiotic or antimicrobial is used for those agents who kill or inhibit the growth of microorganism. The antimicrobials products have significant benefits to the animal and to human food safety. There are researches, which have proven that an increase in the rate of animal illness results in higher rate of human illness. Therefore, livestock dealers depend on animal antibiotics to provide safe food. The scope of this report
Animal Hormones Market Brief Analysis By Top Key Players - Bayer Animal Health, …
MarketStudyReport.com adds a new 2018-2023 Global Animal Hormones Consumption Market Report focuses on the major drivers and restraints for the global key players providing analysis of the market share, segmentation, revenue forecasts and geographic regions of the market. This report presents a comprehensive overview, market shares, and growth opportunities of Animal Hormones Market by product type, application, key manufacturers and key regions. Over the next five years, Animal Hormones market will
Global Animal Healthcare Market 2018 Key Players: Merck, Bayer Animal Health, Bo …
Animal Healthcare Market: WiseGuyReports.com adds “Animal Healthcare Market 2018 Global Analysis, Growth, Trends and Opportunities Research Report Forecasting to 2025” reports to its database. Executive Summary This report studies the global Animal Healthcare market size, industry status and forecast, competition landscape and growth opportunity. This research report categorizes the global Animal Healthcare market by companies, region, type and end-use industry. This report focuses on the global top players, covered Merck Bayer Animal Health Boehringer Ingelheim Animal Hipra Phirbo Animal
Companion Animal Healthcare Market 2023 Leading Players | Bayer Animal Health (G …
The Global Companion Animal Healthcare Market is expected to reach USD 20 billion by 2023 at a CAGR of 9.6% during forecast period 2017 to 2023. Companion animals are pets which are kept for protection of a person, company, property or residence. These animals help to avoid theft and render safe environment. Dog and cats are the most popular pets. Companion animals play an important role in the lives of many,